- Report
- October 2025
Global
From €4384EUR$4,900USD£3,854GBP
From €4384EUR$4,900USD£3,854GBP
- Report
- October 2025
- 138 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- September 2025
- 143 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- September 2025
- 148 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- June 2025
- 141 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- May 2025
- 134 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- March 2025
- 144 Pages
Global
From €2280EUR$2,549USD£2,005GBP
€2683EUR$2,999USD£2,359GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- June 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- May 2025
- 181 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- April 2025
- 183 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- February 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- August 2025
- 194 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 182 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- April 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- February 2025
- 183 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- February 2025
- 182 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more